Stock market today: Dow slips, S&P 500 and Nasdaq waver with Fed rate cut seen as done deal

US equities were mixed Friday but poised for weekly gains, with the Dow briefly surpassing 46,000, as investors anticipate a Federal Reserve rate cut next week, driven by weakening labor data despite stubborn inflation and rising consumer long-term inflation expectations. Key corporate movements included Warner Bros. Discovery surging on reports of a potential acquisition bid from Paramount Skydance, Tesla reaching a seven-month high on optimism surrounding its energy business, and vaccine manufacturers experiencing significant declines following reports of planned government claims linking child deaths to COVID-19 shots.

Analysis

The US equity market is exhibiting divergent performance at record levels, with the Dow Jones Industrial Average retreating 0.4% while the tech-heavy Nasdaq Composite gained 0.3%, as investors position for an anticipated Federal Reserve rate cut next week. This expectation is underpinned by clear signs of a softening labor market, including a mere 20,000 jobs added last month and initial jobless claims hitting a near four-year high. However, this dovish sentiment is contrasted by stubborn inflation, influenced by tariffs, and a notable deterioration in consumer confidence, with the University of Michigan survey showing long-run inflation expectations jumping to 3.9%. Despite these inflationary pressures, CME Group data indicates traders are pricing in a more than 90% probability of a rate cut. Corporate-specific events are driving significant dispersion in returns. Warner Bros. Discovery (WBD) surged 9% on reports of a potential takeover bid from Paramount Skydance, while Tesla (TSLA) shares reached a seven-month high, fueled by bullish analyst commentary on its energy business, which is currently overshadowing concerns about its EV market share. Conversely, vaccine manufacturers like Moderna (MRNA) and BioNTech (BNTX) experienced sharp declines of over 7% and 10% respectively, following a report of potential government claims linking COVID-19 vaccines to child deaths. Furthermore, luxury retailer RH (RH) fell 9% after cutting its annual outlook, explicitly citing margin headwinds from tariffs.

Key Decisions for Investors

• Given the market's aggressive pricing of multiple Fed rate cuts against a backdrop of rising consumer inflation expectations, investors should watch for any hawkish tone in the Fed's forward guidance, which could trigger a market repricing.
• The starkly negative impact of tariffs on RH's outlook serves as a warning; it is prudent to review holdings in consumer discretionary and import-dependent sectors for similar margin vulnerabilities.
• The significant stock moves in Warner Bros. Discovery on M&A news and the sharp sell-off in vaccine stocks highlight the importance of monitoring event-driven catalysts, suggesting a cautious approach to headline-sensitive sectors like biotech while assessing potential arbitrage in media consolidation.
• Consider the continued strength in specific technology narratives, such as Tesla's energy segment and Adobe's AI integration, as sources of alpha that can perform independently of broader macroeconomic concerns.